𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of human T-Cell lymphotropie virus infections in Germany

✍ Scribed by Hermann Schätzl; Gerhard Schwarzfischer; Dietlinde Rose; Birgit Gathof; Wilhelm Weise; Friedrich Deinhardt; Klaus Von Der Helm

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
234 KB
Volume
43
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The extent of human T‐cell lymphotropic retorvirus HTLV‐I and HTLV‐II infections in the general population in central Europe has not been investigated fully. Two hundred forty‐eight thousand blood donors from southern Germany were examined serologically for antibodies to the human lymphotropic retroviruses HTLV‐I and HTLV‐II: 0.021% were confirmed postive and 0.056% were “indeterminate”. A limited number of seropositives and “indeterminate” samples were analyzed by polymerase chain reaction (PCR): the seropositives were confirmed as positive and 43% of the “indeterminate” samples were PCR‐positive. The range of 0.021% HTLV‐positives in 248,000 donors, i.e. about two in 10,000 individuals, mirrors closely the published data for the United States. © 1994 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Low prevalence of hepatitis C virus infe
Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in germany
✍ Ulrich Stölzel; Erich Köstler; Christiane Koszka; Maricka Stöffler-Meilicke; Det 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 1 views

Previous studies from Spain, Italy, and France have demonstrated a high prevalence (71% to 91%) of antibodies against hepatitis C virus in patients with porphyria cutanea tarda (PCT). To determine the role of hepatitis C virus (HCV) in PCT in Germany, we have assessed the prevalence of antibodies ag

Prevalence of herpesvirus, human T-lymph
Prevalence of herpesvirus, human T-lymphotropic virus type 1, and treponemal infections in Southeast Asian refugees
✍ Dr. Dedra Buchwald; Thomas M. Hooton; Rhoda L. Ashley 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract Sera obtained for treponemal serology (VDRL) from 193 Southeast Asian refugees representing five ethnic groups seen in a primary care clinic were examined for antibodies t o human T‐lymphotropic virus type 1 (HTLV‐1), human herpesvirus‐6 (HHV‐6), Epstein‐Barr virus (EBV), and cytomegalo

Prevalence of human T-cell leukemia viru
Prevalence of human T-cell leukemia virus types I and II in Switzerland
✍ Jürg Böni; Leslie R. Bisset; Johann J. Burckhardt; Helen I. Joller-Jemelka; Phil 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract The retroviruses human immunodeficiency virus (HIV)‐1/2 and human T‐cell leukemia virus (HTLV)‐I/II share modes of transmission, suggesting that efforts to monitor the current HIV‐1 epidemic in Switzerland should be complemented by assessment of HTLV‐I/II prevalence. This study presents

Low prevalence of human T-cell leukemia
Low prevalence of human T-cell leukemia virus-I and -II infection among drug users in Amsterdam, the Netherlands
✍ Mrs. J. A. R. Van Den Hoek; E. J. M. Al; J. G. Huisman; J. Goudsmit; R. A. Couti 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

The prevalence of human T-cell leukaemia virus-I and -II infection was studied in a cohort of 346 intravenous and nonintravenous drug users in Amsterdam. Three participants (0.86%) had antibodies to HTLV-I by two commercially available HTLV-I enzyme immunoassays (EIA). Infection in these three subje

Serological speciation of human T-cell l
Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens
✍ Jennifer H. C. Tosswill; Lindsay McAlpine; Philip P. Mortimer 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

## Abstract In order to assess the specificity and sensitivity of two peptide‐based assays (Synth^TM^ HTLV‐I and HTLV‐II enzyme‐linked immunoassay [EIA] [UBI] and Select‐HTLV^TM^ EIA [IAF]) in discriminating between antibody to HTLV‐I and HTLV‐II infection, a panel of 186 well‐characterised serum/p